Holen Sie sich die Stockscreener-App
1.14
3.64%
0.04
Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten
What insider trading reveals about Cocrystal Pharma Inc. stockWeekly Investment Summary & Long-Term Safe Investment Ideas - ulpravda.ru
2026 world cup england qualifiers formations trends2025 Winners & Losers & Free High Return Stock Watch Alerts - ulpravda.ru
How buybacks impact Starz Entertainment LLC stock valueTrade Ideas & Free Expert Verified Stock Movement Alerts - ulpravda.ru
Easy Fincorp Limited Shows Early Signs of Technical StrengthJuly 2025 PreEarnings & AI Driven Stock Reports - ulpravda.ru
Why PTON stock is seen as undervaluedEarnings Performance Report & Smart Swing Trading Alerts - ulpravda.ru
Should I hold or sell Cocrystal Pharma Inc. stock in 20252025 Bull vs Bear & Weekly Market Pulse Alerts - ulpravda.ru
Aug Technicals: What insider trading reveals about Cocrystal Pharma Inc. stockPortfolio Performance Summary & Accurate Intraday Trading Signals - ulpravda.ru
Will Cocrystal Pharma Inc. stock split attract more investorsWeekly Investment Recap & Accurate Entry/Exit Alerts - ulpravda.ru
Will Cocrystal Pharma Inc. stock outperform Nasdaq indexQuarterly Trade Summary & High Accuracy Investment Entry Signals - ulpravda.ru
Why PFXF stock is trending on social media2025 Support & Resistance & Verified Technical Trade Signals - ulpravda.ru
Volume Recap: How strong is CBRE Group Inc. stock revenue growth2025 Dividend Review & AI Based Trade Execution Alerts - ulpravda.ru
Phillip Md Et Al Frost Purchases 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock - Defense World
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Buyback Watch: How analysts rate Cocrystal Pharma Inc stock todayBull Run & Weekly Watchlist for Hot Stocks - moha.gov.vn
Financial Survey: CytomX Therapeutics (NASDAQ:CTMX) versus Cocrystal Pharma (NASDAQ:COCP) - Defense World
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k By Investing.com - Investing.com Nigeria
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Aug Decliners: Will Cocrystal Pharma Inc. stock split attract more investors - moha.gov.vn
Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - Улправда
Why Cocrystal Pharma Inc. stock is a must watch in 2025Market Performance Summary & Safe Entry Momentum Stock Tips - Улправда
Rally Mode: Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Safe Capital Growth Stock Tips - Улправда
Why Cocrystal Pharma Inc. (8CC) stock could be top winnerJuly 2025 Sentiment & High Conviction Investment Ideas - moha.gov.vn
Is Cocrystal Pharma Inc. stock a safe haven assetJuly 2025 Price Swings & AI Powered Market Entry Strategies - DonanımHaber
Will Cocrystal Pharma Inc. stock gain from government policiesMarket Volume Summary & Long-Term Capital Growth Ideas - bolumsonucanavari.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial By Investing.com - Investing.com Australia
Can Cocrystal Pharma Inc. stock deliver strong Q4 earnings2025 EndofYear Setup & High Conviction Buy Zone Picks - DonanımHaber
Sentiment Recap: Why Cocrystal Pharma Inc. stock is a must watch in 2025Dip Buying & Short-Term High Return Ideas - Улправда
[8-K] Cocrystal Pharma, Inc. Reports Material Event | COCP SEC FilingForm 8-K - Stock Titan
Cocrystal Pharma, Inc. Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - marketscreener.com
Cocrystal Pharma (COCP) Set to Begin Norovirus Study with IRB Ap - GuruFocus
Cocrystal Pharma gains IRB approval for norovirus trial - TipRanks
Cocrystal Pharma Initiates Phase 1b Study for Norovirus Treatment - TradingView — Track All Markets
Cocrystal Pharma receives IRB approval from Emory University School of Medicine - marketscreener.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial - Investing.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - GlobeNewswire
Cocrystal Pharma (NASDAQ:COCP) Shares Down 3.5% – Here’s What Happened - Defense World
Cocrystal Pharma Earnings Notes - Trefis
EPS Watch: Can Cocrystal Pharma Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Portfolio Update: Is Cocrystal Pharma Inc stock trading near support levelsWeekly Investment Report & Low Risk Investment Opportunities - moha.gov.vn
Revenue per share of Cocrystal Pharma Inc – FWB:8CC - TradingView
Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser
Published on: 2025-12-02 05:48:00 - Newser
How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser
How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser
Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser
Cocrystal Pharma to Present at Emerging Growth Conference - TipRanks
Cocrystal Pharma to Present at Noble Capital Markets Conference - TradingView
COCP Insider Trading - Quiver Quantitative
Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - marketscreener.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com South Africa
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):